J. Abu-Omar

Combination of Fat-Free Muscle Index and Total Spontaneous Portosystemic Shunt Area Identifies High-Risk Cirrhosis Patients

C. Strassburg, A. Faron, J. Rockstroh, 2022, Frontiers in Medicine.

Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation

C. Strassburg, J. Trebicka, M. Merli, 2021, JHEP reports : innovation in hepatology.

Alteration of contrast enhanced ultrasound (CEUS) of hepatocellular carcinoma in patients with cirrhosis and transjugular intrahepatic portosystemic shunt (TIPS)

C. Strassburg, J. Rockstroh, J. Trebicka, 2020, Scientific Reports.